Please use this identifier to cite or link to this item: http://hdl.handle.net/10995/101482
Title: HIV/SARS-CoV-2 coinfection: A global perspective
Authors: Kanwugu, O. N.
Adadi, P.
Issue Date: 2021
Publisher: John Wiley and Sons Inc
Citation: Kanwugu O. N. HIV/SARS-CoV-2 coinfection: A global perspective / O. N. Kanwugu, P. Adadi. — DOI 10.1002/jmv.26321 // Journal of Medical Virology. — 2021. — Vol. 93. — Iss. 2. — P. 726-732.
Abstract: Since its first appearance in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread throughout the world and has become a global pandemic. Several medical comorbidities have been identified as risk factors for coronavirus disease 2019 (COVID-19). However, it remains unclear whether people living with human immunodefeciency virus (PLWH) are at an increased risk of COVID-19 and severe disease manifestation, with controversial suggestion that HIV-infected individuals could be protected from severe COVID-19 by means of antiretroviral therapy or HIV-related immunosuppression. Several cases of coinfection with HIV and SARS-CoV-2 have been reported from different parts of the globe. This review seeks to provide a holistic overview of SARS-CoV-2 infection in PLWH. © 2020 Wiley Periodicals LLC
Keywords: ANTIRETROVIRAL THERAPY/COINFECTION
COVID-19
HIV
IMMUNODEFICIENCY
CLINICAL FEATURE
COMORBIDITY
CORONAVIRUS DISEASE 2019
DISEASE ASSOCIATION
DISEASE SEVERITY
HIGH INCOME COUNTRY
HUMAN
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION
INFECTION RISK
MIXED INFECTION
NONHUMAN
PANDEMIC
REVIEW
VIRUS LOAD
ADULT
CD4+ T LYMPHOCYTE
DIABETES MELLITUS
DRUG EFFECT
FEMALE
GROWTH, DEVELOPMENT AND AGING
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
HUMAN IMMUNODEFICIENCY VIRUS
HUMAN IMMUNODEFICIENCY VIRUS INFECTION
HYPERTENSION
IMMUNOCOMPROMISED PATIENT
IMMUNOLOGY
MALE
MIDDLE AGED
MIXED INFECTION
MORTALITY
PANDEMIC
PATHOGENICITY
PATHOPHYSIOLOGY
SURVIVAL ANALYSIS
TREATMENT OUTCOME
VIROLOGY
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT
ADULT
ANTI-HIV AGENTS
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE
CD4-POSITIVE T-LYMPHOCYTES
COINFECTION
COMORBIDITY
COVID-19
DIABETES MELLITUS
FEMALE
HIV
HIV INFECTIONS
HUMANS
HYPERTENSION
IMMUNOCOMPROMISED HOST
MALE
MIDDLE AGED
PANDEMICS
SARS-COV-2
SURVIVAL ANALYSIS
TREATMENT OUTCOME
URI: http://hdl.handle.net/10995/101482
Access: info:eu-repo/semantics/openAccess
SCOPUS ID: 85088583592
PURE ID: 20377699
51bf165d-0ab5-4bcc-a955-a0fad89dc5b3
ISSN: 1466615
DOI: 10.1002/jmv.26321
Appears in Collections:Научные публикации, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-85088583592.pdf1,12 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.